193 related articles for article (PubMed ID: 15039213)
21. 17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells.
Pandini G; Genua M; Frasca F; Squatrito S; Vigneri R; Belfiore A
Cancer Res; 2007 Sep; 67(18):8932-41. PubMed ID: 17875736
[TBL] [Abstract][Full Text] [Related]
22. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo.
Raffo AJ; Perlman H; Chen MW; Day ML; Streitman JS; Buttyan R
Cancer Res; 1995 Oct; 55(19):4438-45. PubMed ID: 7671257
[TBL] [Abstract][Full Text] [Related]
24. [FAK/c-Src signaling pathway mediates the expression of cell surface HSP90 in cultured human prostate cancer cells and its association with their invasive capability].
Liu XG; Guo Y; Yan ZQ; Guo MY; Zhang ZG; Guo CA
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):340-4. PubMed ID: 21875461
[TBL] [Abstract][Full Text] [Related]
25. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells.
Li YY; Wu Y; Tsuneyama K; Baba T; Mukaida N
Cancer Sci; 2009 Mar; 100(3):396-404. PubMed ID: 19154409
[TBL] [Abstract][Full Text] [Related]
26. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
[TBL] [Abstract][Full Text] [Related]
27. A cell- and developmental stage-specific promoter drives the expression of a truncated c-kit protein during mouse spermatid elongation.
Albanesi C; Geremia R; Giorgio M; Dolci S; Sette C; Rossi P
Development; 1996 Apr; 122(4):1291-302. PubMed ID: 8620856
[TBL] [Abstract][Full Text] [Related]
28. Tr-kit-induced resumption of the cell cycle in mouse eggs requires activation of a Src-like kinase.
Sette C; Paronetto MP; Barchi M; Bevilacqua A; Geremia R; Rossi P
EMBO J; 2002 Oct; 21(20):5386-95. PubMed ID: 12374739
[TBL] [Abstract][Full Text] [Related]
29. Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit.
Mano H; Mano K; Tang B; Koehler M; Yi T; Gilbert DJ; Jenkins NA; Copeland NG; Ihle JN
Oncogene; 1993 Feb; 8(2):417-24. PubMed ID: 7678927
[TBL] [Abstract][Full Text] [Related]
30. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.
Cance WG; Craven RJ; Bergman M; Xu L; Alitalo K; Liu ET
Cell Growth Differ; 1994 Dec; 5(12):1347-55. PubMed ID: 7696183
[TBL] [Abstract][Full Text] [Related]
31. ErbB2/Her-2 regulates the expression of Akt2 in prostate cancer cells.
Le Page C; Koumakpayi IH; Péant B; Delvoye N; Saad F; Mes-Masson AM
Prostate; 2012 May; 72(7):777-88. PubMed ID: 21932427
[TBL] [Abstract][Full Text] [Related]
32. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells.
Derry JJ; Prins GS; Ray V; Tyner AL
Oncogene; 2003 Jul; 22(27):4212-20. PubMed ID: 12833144
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
[TBL] [Abstract][Full Text] [Related]
34. The Interrelationship Between
Ergün S; Akgün O; Hekim NT; Aslan S; Ari F; Güneş S; Abur Ü
Anticancer Agents Med Chem; 2023; 23(3):360-365. PubMed ID: 35652400
[TBL] [Abstract][Full Text] [Related]
35. A functional truncated form of c-kit tyrosine kinase is produced specifically in the testis of the mouse but not the rat, pig, or human.
Sakamoto A; Yoneda A; Terada K; Namiki Y; Suzuki K; Mori T; Ueda J; Watanabe T
Biochem Genet; 2004 Dec; 42(11-12):441-51. PubMed ID: 15587987
[TBL] [Abstract][Full Text] [Related]
36. Investigation of c-KIT and Ki67 expression in normal, preneoplastic and neoplastic canine prostate.
Fonseca-Alves CE; Kobayashi PE; Palmieri C; Laufer-Amorim R
BMC Vet Res; 2017 Dec; 13(1):380. PubMed ID: 29207991
[TBL] [Abstract][Full Text] [Related]
37. Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis.
Wasag B; Niedoszytko M; Piskorz A; Lange M; Renke J; Jassem E; Biernat W; Debiec-Rychter M; Limon J
Exp Hematol; 2011 Aug; 39(8):859-65.e2. PubMed ID: 21689725
[TBL] [Abstract][Full Text] [Related]
38. Src family kinases are involved in the differential signaling from two splice forms of c-Kit.
Voytyuk O; Lennartsson J; Mogi A; Caruana G; Courtneidge S; Ashman LK; Rönnstrand L
J Biol Chem; 2003 Mar; 278(11):9159-66. PubMed ID: 12511554
[TBL] [Abstract][Full Text] [Related]
39. Involvement of phospholipase Cgamma1 in mouse egg activation induced by a truncated form of the C-kit tyrosine kinase present in spermatozoa.
Sette C; Bevilacqua A; Geremia R; Rossi P
J Cell Biol; 1998 Aug; 142(4):1063-74. PubMed ID: 9722617
[TBL] [Abstract][Full Text] [Related]
40. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.
Tamborini E; Bonadiman L; Greco A; Gronchi A; Riva C; Bertulli R; Casali PG; Pierotti MA; Pilotti S
Clin Cancer Res; 2004 Feb; 10(3):938-43. PubMed ID: 14871970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
